This unique feature allows telmisartan to improve insulin sensitivity and decrease hepatic fat accumulation via the modulation of PPARγ, as well as suppress hepatic fibrosis by blocking angiotensin II receptors14,15. Here, PPARG is linked to Hepatic fibrosis.